Subcutaneous Panniculitis-Like T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis.
Nhu Tung TranKhac Tuyen NguyenLinh Thi LeKhuyen Thi NguyenCong Thao TrinhVan Trung HoangPublished in: Journal of investigative medicine high impact case reports (2024)
Subcutaneous panniculitis-like T-cell lymphoma (SPTLP), a unique variant of primary cutaneous T-cell lymphomas, clinically mimics subcutaneous panniculitis. It is typified by the development of multiple plaques or subcutaneous erythematous nodules, predominantly on the extremities and trunk. Epidemiological findings reveal a greater incidence in females than males, affecting a wide demographic, including pediatric and adult cohorts, with a median onset age of around 30 years. Diagnosis of SPTLP is complex, hinging on skin biopsy analyses and the identification of T-cell lineage-specific immunohistochemical markers. Treatment modalities for SPTLP are varied; while corticosteroids may be beneficial initially for many patients, a substantial number require chemotherapy, especially in cases of poor response or relapse. Generally, SPTLP progresses slowly, yet approximately 20% of cases advance to hemophagocytic lymphohistiocytosis (HLH), often correlating with a negative prognosis. We report a case of a young male patient presenting with prolonged fever, multiple skin lesions accompanied by HLH, a poor clinical course, and eventual death, diagnosed postmortem with SPTLP. In addition, we also present a literature review of the current evidence of some updates related to SPTLP.
Keyphrases
- case report
- end stage renal disease
- soft tissue
- newly diagnosed
- chronic kidney disease
- ejection fraction
- single cell
- wound healing
- risk factors
- peritoneal dialysis
- prognostic factors
- patient reported outcomes
- genome wide
- radiation therapy
- young adults
- combination therapy
- childhood cancer
- rectal cancer
- replacement therapy